Cortisone in Ulcerative Colitis

1955/10/29 by S. C. Truelove, L. J. Witts · 2,796 citations
Medicine · #Colitis #Cortisone #Disease #Gastroenterology #Internal medicine #Medicine #Microscopic Colitis #Ulcerative colitis

paper · pdf · doi:10.1136/bmj.2.4947.1041

published in BMJ 2(4947), 1041-1048

openalex publication_date 1955/10/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Abstract

In a preliminary report (Truelove and Witts, 1954) we have given the immediate results of a controlled trial of cortisone in the treatment of chronic ulcerative colitis.

Citations

• Cortisone in Ulcerative Colitis

Cited by

• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
• Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
• Mucosal Healing in Ulcerative Colitis: A Comprehensive Review
• AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
• AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
• Ulcerative Colitis
• Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
• Assessing Severity of Disease in Patients with Ulcerative Colitis
• Acute severe ulcerative colitis without systemic toxicity: A retrospective multicenter cohort study suggesting refining the definition of acute severe ulcerative colitis
• Ulcerative colitis
• Ulcerative colitis
• Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience
• Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
• Tropomyosin isoforms in intestinal mucosa: Production of autoantibodies to tropomyosin isoforms in ulcerative colitis☆☆☆★
• The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis
• Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. [europepmc]
• Inflammatory bowel disease: past, present, and future. [europepmc]
• Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. [europepmc]
• Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India. [europepmc]
• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. [europepmc]
• Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. [europepmc]
• Evidence-based clinical practice guidelines for inflammatory bowel disease. [europepmc]
• Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. [europepmc]
• Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. [europepmc]
• AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. [europepmc]
• AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. [europepmc]
• Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. [europepmc]
• Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. [europepmc]
• A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. [europepmc]
• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. [europepmc]
• AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis. [europepmc]
• AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. [europepmc]
• Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. [europepmc]
• Assessing Severity of Disease in Patients with Ulcerative Colitis. [europepmc]
• Ulcerative Colitis-Diagnostic and Therapeutic Algorithms. [europepmc]
• Intestinal Mucosal Wound Healing and Barrier Integrity in IBD-Crosstalk and Trafficking of Cellular Players. [europepmc]
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. [europepmc]
• Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice. [europepmc]
• Treatment of Inflammatory Bowel Disease: A Comprehensive Review. [europepmc]
• Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. [europepmc]

Related

• Impact of concomitant corticosteroid use on adverse events in ulcerative colitis clinical trials
• Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
• Mucosal Healing in Ulcerative Colitis: A Comprehensive Review
• Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
• Acute severe ulcerative colitis without systemic toxicity: A retrospective multicenter cohort study suggesting refining the definition of acute severe ulcerative colitis